Post My Press Release

Free Press Release Distribution

Category: Pharmaceutical Industry (Page 1 of 35)

Inhalation Anesthesia Market New Opportunities For Industry Growth And Forecast To 2025 : Grand View Research Inc.

San Francisco, 24 May 2019: The Report Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Isoflurane, Desflurane), By Region, And Segment Forecasts, 2019 – 2025

The global Inhalation Anesthesia Market size is projected to reach USD 1.42 billion by 2015, at a lucrative CAGR of 3.5% over the forecast period, according to a new report by Grand View Research, Inc. Key factors contributing to its rapid growth include increasing prevalence of cancer, cardiovascular, respiratory, neurological, gastrointestinal, orthopedic, and spinal diseases and disorders.

Furthermore, increasing number of emergency cases and demand for short stay ambulatory day care surgical procedure are amongst critical success factors attributed to the market growth. Access to universal health insurance coverage for a wider population base coupled with constant improvements in healthcare infrastructure in various developing countries are expected to positively impact the number of surgeries performed, thus increasing the usage of inhalation anesthetics.

On the basis of product, the inhalation anesthesia market is classified into sevoflurane, isoflurane, and desflurane. These products are used for induction and maintenance of anesthesia for patients during surgical procedures. Sevoflurane led the product segment in 2018 and is anticipated to grow at a lucrative rate over the forecast period, attributed to its therapeutic advantages, low cost, and higher potency for the induction of anesthesia. On the other hand, isoflurane is expected to witness the fastest CAGR of 6.3% over the forecast period, due to its increasing use in maintenance of anesthesia for treatment of weak or geriatric patients owing to its sparing effect on cardiovascular function.

On the basis of regions, the market is broadly classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America held the leading market share of USD 456.0 million and is anticipated to witness lucrative CAGR over the forecast period. This is owing to increasing prevalence of chronic diseases coupled with the presence of advanced healthcare facilities. On the other hand, Asia Pacific was anticipated to witness the fastest CAGR of 4.0% due to increasing population and number of patients suffering from chronic population.

Some of the key players operating in this market include Halocarbon Products Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc.

Access Research Report of Inhalation Anesthesia Market @ www.grandviewresearch.com/industry-analysis/inhalation-anesthesia-market

Further key findings from the report suggest:

  • Sevoflurane product segment led the market in terms of revenue, valued at USD 768.6 million, in 2018
  • Isoflurane product segment is anticipated to expand at the fastest CAGR of 6.3% owing to its increasing use in the treatment of weak and geriatric patients owing to its low effect on cardiovascular function
  • North America led the market in 2018 with a revenue of USD 456.0 million owing to the presence of advanced healthcare facilities, strong reimbursement scenario, and prevalence of chronic diseases
  • Key players operating in the inhalation anesthesia market include Halocarbon Products Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global inhalation anesthesia market on the basis of product and region:

Inhalation Anesthesia Product Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Sevoflurane
  • Isoflurane
  • Desflurane

Inhalation Anesthesia Application Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Induction
  • Maintenance

Inhalation Anesthesia Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • NorthAmerica
  • Europe
  • AsiaPacific
  • Latin America
  • MEA

Access Press Release of Inhalation Anesthesia Market @ www.grandviewresearch.com/press-release/global-Inhalation-Anesthesia-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

High Potency Active Pharmaceutical Ingredients (APIs) Market Detailed Analysis For Industry Size, Share And Future Assumptions For 2025 : Grand View Research Inc.

San Francisco, 24 May 2019: The Report High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis By Product (Synthetic, Biotech), Manufacturer (In-house, Outsourced), Drug Type, Therapeutic Application (Oncology, Hormonal, Glaucoma, Others), And Segment Forecasts, 2018 – 2025

The global High Potency Active Pharmaceutical Ingredients (APIs) Market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. 

In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.

Access Research Report of High Potency Active Pharmaceutical Ingredients (APIs) Market @ www.grandviewresearch.com/industry-analysis/high-potency-active-pharmaceutical-ingredients-hpapi-market

Further Key Findings From the Study Suggest:

  • Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules
  • Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it
  • Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment
  • Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development
  • Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs
  • North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market
  • Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth
  • Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market
  • The key players in the HPAPI market includeBristol-Myers Squibb,  Sigma-Aldrich Corporation, Pfizer Incand Lonza among others
  • Extensive research and development activities carried out by market participants is also expected to augment the market growth

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the High PotencyAPIsmarket on the basis of the product, manufactures, drug types, application, and region:

HPAPIs Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Synthetic
  • Biotech

HPAPIs Manufacturers Outlook (Revenue, USD Million, 2014 – 2025)

  • In-house
  • Outsourced

HPAPIs Drug Types Outlook (Revenue, USD Million, 2014 – 2025)

  • Innovative
  • Generic

HPAPIs Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Oncology
  • Hormonal
  • Glaucoma
  • Others

HPAPIs Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of High Potency Active Pharmaceutical Ingredients (APIs) Market @ www.grandviewresearch.com/press-release/global-high-potency-active-pharmaceutical-ingredients-hpapi-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Caps & Closures Market is expected to witness a CAGR of more than 5.62% between 2016 and 2021

[199 Pages report] The Caps & Closures Market size is estimated to grow from USD 49.78 Billion in 2015 to USD 68.71 Billion by 2021, at a CAGR of 5.62%. The base year considered for the study is 2015 and the market size is projected from 2016 to 2021. The report covers study of the various segments that are part of the manufacturing process of caps & closures and the end consumers. Thus, segmentation for the caps & closures market includes by raw material, type, and application. The report covers detail study on key parameters such as market drivers, restraints, opportunity and challenges which is hindering growth of this industry. The report also aims to study the individual growth trends, future prospects, and contribution of various segments to the total market.

Request for free sample report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1314

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Caps & Closures Market, By Raw Material

7 Caps & Closures Market, By Type

8 Caps & Closures Market, By End-Use Industry

9 Caps & Closures Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

The beverages segment dominated the market in 2015 and is projected to be the second-fastest-growing end-user industry in the next five years, as a result of the rising consumer demand for beverage products such as bottled water and beer as well as growing demand for quality and safe products. Furthermore, the healthcare segment is projected to be the fastest-growing end-use industry due to the rising consumption of pharmaceutical and medical products.

The Asia-Pacific region leads the market due to its large population and its proven identity of a major manufacturing hub that offers production opportunities at affordable costs to companies. As caps & closures are used widely by different industries, such as food, beverages, and healthcare, the Asia-Pacific region, which is witnessing major growth in these sectors as well, has become a large market for these packaging solutions. This is followed by North America, which is the next largest market for caps & closures followed by Europe and Rest of the World.

The global market for caps and closures is dominated by players such as RPC Group Plc (U.K.), Reynolds Group Holdings Limited (New Zealand), Crown Holdings Inc. (U.S.), Amcor Limited (Australia), Rexam PLC (U.K.), Berry Plastics Corporation (U.S.), Silgan Holdings Inc. (U.S.), AptarGroup Inc. (U.S.), Guala Closures Group (Italy), and BERICAP GmbH Co. & KG (Germany).

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Caps & Closures Market.

Read Our blog for more details: http://bit.ly/2DlIYqB

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Sheep Placenta Extract Market 2019 Report Insights, CAGR Status, Business Outlook and Key players

A sheep placenta extract is a rich source of nutrients, bioactive cytokines, and growth factors. Many scientific studies have shown that sheep placenta contains special proteins, which promotes cell growth, strengthens the immune system, and regulates the hormone secretion. Key factors that drive the growth of this market are the increasing use of sheep placenta in skin care products and hair care products globally. However, low awareness among individuals especially in developing economies regarding sheep placenta extract and their dosages will certainly impede the market growth. Moreover, R&D investments in untapped regions such as Asia-Pacific will create lucrative opportunities for key market players.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-toc-and-sample/3901

The global sheep placenta extract market is segmented based on product type, applications, and geography. Based on product type this market is segmented into sheep placenta extract powders and sheep placenta extract fluids. Based on applications this market is segmented into dietary, pharmaceutical, and cosmetics. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as BioContinental, Galtec Australia, Anzchem Pty Ltd, BIOFAC A/S, XABC Biotech Co., Ltd, Lanzhou Mingde, Shaanxi Sciphar, Xian Shandao Co, Suzhou Tianlong Co Ltd and Neimenggu Xinhong Biotech Co., Ltd have also been provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global sheep placenta extract market.
  • In-depth analysis has been carried out in this report by constructing market estimations for key market segments between 2017 and 2023.
  • Geographically, the global sheep placenta extract market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
  • This study that evaluates the competitive landscape and value chain has been taken into account to help understand the competitive environment globally.
  • Comprehensive analysis of factors that drive and restrict the growth of the global sheep placenta extract market has been provided.
  • This report provides the quantitative analysis of the current market and estimations from 2017-2023, which assists in identifying prevailing market opportunities
  • Comprehensive analysis of all regions has been provided that determines prevailing opportunities in these geographies.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3901

Aminoglycosides Market Is Likely To Up Demand At A USD 1.68 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022

Global Aminoglycosides Market is expected to reach USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the increasing incidences of animal disease outbreaks leading to high utilization of antibiotics. 

However, reduction in prescription rate of aminoglycoside antibiotics due to side effects associated with usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade are expected to affect the market growth negatively. Furthermore, regulatory disapproval for the usage of certain aminoglycoside in regions is also anticipated to attribute for subordinate growth in this industry. 

Access Research Report of Aminoglycosides Market @ www.grandviewresearch.com/industry-analysis/aminoglycoside-market

Further key findings from the report suggest:

  • Neomycin and tobramycin together contributed for over USD 600 million as revenue in this market owing to higher usage and prescription of these drugs for treatment of different bacterial infections. Neomycin finds higher usage in topical formulations for treatment of different skin infections.
  • Injectables accounted for the largest share of revenue amongst other routes of administration owing to higher usage for treatment of tuberculosis, MDR-TB, and XDR-TB. Use of second line anti tuberculosis drugs such as kanamycin & capreomycin by global organizations is attributive for generation of maximum revenue in this segment.
  • Human use for treatment of respiratory disorders accounted for largest share in applications segment owing to rise in global incidence of tuberculosis. Furthermore, other bacterial infections of respiratory tract that can be treated using aminoglycoside class of antibiotics are anticipated to contribute for expected growth in this segment.
  • Veterinary treatment is expected to boost industrial growth in the coming years owing to higher incidence of animal diseases outbreaks. However, these drugs have restrictive regulations for administration to food-producing animals as it may lead to toxic effects and resistance development on humans after consumption of animal originated food.
  • Asia Pacific was the largest market, accounting for over 40% of revenue in aminoglycoside industry owing to, the presence of market players in this region coupled with higher rate of tuberculosis incidences herein.
  • South Africa spearheaded growth in the MEA market. The presence of relatively higher demand and consumption of injectable solutions in this region because of increase in incidence rate of MDR-TB and other drug resistant infections are some regional growth drivers.
  • Key participants of the aminoglycoside market include Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd.
  • Market players are involved in the development of products with newer formulations and lesser side effects in order to treat eradicate bacterial infections that are resistant to other class of antibiotics.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented aminoglycoside market on the basis of product, route of administration, application, and region:

Aminoglycoside Product Outlook (Market Revenue in USD Million, 2012 – 2022 )

  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin
  • Others

Aminoglycoside Outlook, by Route of Administration (Market Revenue in USD Million, 2012 – 2022)

  • Injectables
  • Feed
  • Intra-mammary
  • Topical
  • Oral

Aminoglycoside Application Outlook (Market Revenue in USD Million, 2012 – 2022)

  • Veterinary
  • Skin Infection
  • Respiratory diseases
  • UTI & Pelvic Diseases
  • Other diseases

Aminoglycoside Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Aminoglycosides Market @ www.grandviewresearch.com/press-release/global-aminoglycoside-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Silicon Nitride Market expected to be worth 127 Million USD by 2023, at a CAGR of 7.2%, from 2018–2023

According to the new market research report “Silicon Nitride Market by Type (Reaction Bonded Silicon Nitride, Hot Pressed Silicon Nitride, Sintered Silicon Nitride), End-use Industry (Photovoltaic, Automotive, General Industrial, Aerospace, Medical), and Region – Global Forecast to 2023”, published by MarketsandMarkets™, the Silicon Nitride Market is estimated at USD 90 million in 2018 and is projected to reach USD 127 million by 2023, at a CAGR of 7.2% between 2018 and 2023. The need for high-performance materials in demanding applications is expected to drive the market.

Request for free PDF sample report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55313811

The leading players in the silicon nitride market can be classified into silicon nitride powder producers and fabricators of silicon nitride powder. The leading silicon nitride powder producers are UBE (Japan), Denka (Japan), AlzChem (Germany), H.C. Starck (Germany), and Yantai Tomley Hi-Tech Advanced Materials Co Ltd (China). The leading fabricators of silicon nitride are 3M (US), CeramTec (Germany), Kyocera Fine Ceramics (Japan), Morgan Advanced Ceramics (UK), Toshiba (Japan), Rogers Corporations (US), and CoorsTek (US). These players adopted acquisitions, new product launches, and agreements as key growth strategies between 2014 and 2018, which helped them increase their capacities and cater to the widening customer base.

 Denka is one of the leading players in the silicon nitride market. The company manufactures silicon nitride under its electronics & innovative products business segment. Denka has its presence in APAC, North America, the Middle East & Africa, and Europe. The company’s product offering includes silicon nitride powder as well as silicon nitride substrates. Denka also adopted inorganic and organic growth strategies to maintain its position in the global silicon nitride market. In January 2019, the company has planned to make an investment for the expansion of its silicon nitride ceramic substrates manufacturing by three folds. The expansion is expected to help the company cater to the demand for silicon nitride in automotive applications. The plant is expected to be operational by 2021. In November 2018, Denka and Mitsubishi Materials Corporation (Japan) reached an agreement to jointly develop ceramic substrates that can be used in the power module for the motor drive of EVs and other eco-friendly vehicles. This would help Denka’s plan toward full-fledged mass production of ceramic substrates for EVs.

 CeramTec (Germany) manufactures and distributes products such as aluminum oxide, piezo ceramics, silicate ceramics, zirconium oxide, aluminum nitride, silicon carbide, and silicon nitride. These products are used in end-use industries such as automotive, aerospace, machinery, electronics, and medical equipment. CeramTec acquires UK electro-ceramics business from Morgan Advanced Materials. Morgan Advanced Materials have business segments, namely, industrial, petrochemical, transportation, security & defense, energy, electronics, and healthcare. The company’s subsidiary, Morgan Technical Ceramics, manufactures products such as alumina, aluminum nitride, diamond-like carbon, pyrolytic boron nitride, fused silica, silica zircon, silicon carbide, magnesium oxide, alumina silicates, mulita, silicon nitride, braze alloys, zirconia, and nilcra SiAlON. This acquisition by CeramTec is expected to increase the business of the company, which will serve the needs of end-use industries such as electronics, medical, and defense.

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Silicon Nitride Market.

Read our blog for more details: https://chemabd007.blogspot.com/2019/05/silicon-nitride-market-expected-to.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Cancer Supportive Care Drugs Market Determined To Reach USD 23.5 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report  Cancer Supportive Care Drugs Market Analysis Report By Therapeutic Class (G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs), By Major Markets, Vendor Landscape, And Segment Forecasts, 2016 – 2022

The global Cancer Supportive Care Drugs Market size is expected to be valued at USD 23.5 billion by 2022, as per a new report by Grand View Research, Inc., progressing at a CAGR of 1.8% during the forecast period. The market is anticipated to be driven by large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored treatments.

Chemotherapy and radiotherapy are traditional methods for cancer treatment with approximately four million people receiving chemotherapy every year. Supportive care products are essential to prevent and manage symptoms and side-effects of cancer and its treatment.Among major cancer types, lung and breast cancers are the most prominent cancer type with the highest demand for supportive care drugs.

G-CSFs and ESAs therapeutic classes are witnessing a fundamental shift from biologics to biosimilars. The market for cancer pain, chemotherapy induced nausea and vomiting, and cancer induced bone diseases will grow significantly during the forecast period, due to new product launches and high unmet needs. The cancer pain market is estimated to witness a shift from opioids to non-opioids therapies. The shift will be backed by patent loss, high mortality, addiction, and major safety issues associated with narcotic agents.

Access Research Report of Cancer Supportive Care Drugs Market @  www.grandviewresearch.com/industry-analysis/cancer-supportive-care-drugs-market

Further key findings from the report suggest:

  • Some of the key players operating in this industry are Amgen, Johnson & Johnson, Merck, Roche, Helsinn Healthcare, Heron Pharma, and Tesaro
  • Among EU5, Germany captured the second position in the global cancer support care drugs market. Japan is poised to witness the fastest growth over the forecast period
  • The CINV drugs market will be propelled by widening base of patients, increasing adoption of chemotherapeutic drugs, and launch of new drug delivery approaches to improve patient compliance
  • In Europe, Zarzio has taken over its reference product Neupogen in terms of market share
  • Late stage pipeline products include non-opioids such as Tanezumab and HTX-011
  • Newer immunotherapies directed against PD-1 ligands and PD-L1 proteins have shown to be more effective with a superior safety profile

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cancer supportive care drugs market based on drug class and treatment:

Cancer Supportive Care Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 – 2022)

  • G-CSFs
  • ESAs
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs and others

Cancer Supportive Care Drugs Regional Outlook (Revenue, USD Million, 2016 – 2022)

  • U.S.
  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Japan

Access Press Release of Cancer Supportive Care Drugs Market @ www.grandviewresearch.com/press-release/global-cancer-supportive-care-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Metal Nanoparticles Market Global Industry Overview and Competitive Landscape till 2022

The [149 Pages Report] “Metal Nanoparticles Market by metal (Platinum, Gold, Silver, Iron, Titanium, Copper, Nickel), End-use industry (Pharmaceutical & healthcare, Electrical & electronics, Catalyst, Personal care & cosmetics), and Region – Global Forecast to 2022″ published by MarketsandMarkets™, the Metal Nanoparticles Market size is estimated to grow from USD 12.35 Billion in 2017 to USD 25.26 Billion by 2022, at a CAGR of 15.4%. The market is projected to witness steady growth in the next few years, because of the increasing application areas of metal nanoparticles, resulting from rapid industrialization and urbanization. Large-scale investments in industrial sectors, rise in demand for innovative materials from the healthcare industry, and supportive government initiatives & funding are some of the key factors driving the growth of the Metal Nanoparticles Market.

Request for free PDF sample report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138262033

The metal nanoparticles market is led by major players such as American Elements (US), Nanoshel (US), Nanostructured & Amorphous Materials (US), EPRUI Nanoparticles & Microspheres (China), and US Research Nanomaterials (US). Extensive product portfolio, coupled with network of facilities across the globe, contributes toward the leading position of these market players. The market players focus on the advancement of sustainable technologies, commercializing emerging green technology, and promoting greater eco-efficiency which further boosts their market position in the global metal nanoparticles market.

 American Elements (US) is a leading metal nanoparticles manufacturer. Strong global presence, wide product portfolio comprising over 15,000 products, and focus toward the advancement of sustainable technologies have helped the company to establish a leading position in metal nanoparticles market. Its fundamental expertise in the cost-effective manufacturing of engineered and advanced materials enables the company to meet the demand of thousands of global customers. Through its network of production facilities globally, it also produces customer proprietary formulations. Its customer base in multiple countries further contributes to its leading position.

 Nanoshel (US) is another key player in the metal nanoparticles market. It is the manufacturer and supplier of innovative materials & nanoparticles and offers breakthrough solutions through its expertise in nanomaterials.

Its strong global presence with offices in both developed and developing countries, wide variety of metal nanoparticles, and skilled R&D team strengthen its position in the global market. The company is focused on developing innovative technologies and exploring markets to expand its market presence.

The global metal nanoparticles market is dominated by players such as American Elements (US), Nanoshel (US), Nanostructured & Amorphous Materials (US), EPRUI Nanoparticles & Microspheres (China), US Research Nanomaterials (US), Meliorum Technologies (US), nanoComposix (US), BBI Group (UK), Nanocs (US), Strem Chemicals (US), and Tanaka Holdings (Japan).

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Metal Nanoparticles Market.

Read our blog for more details: https://chemabd007.blogspot.com/2019/05/metal-nanoparticles-market-is-expected.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Page 1 of 35

Powered by WordPress & Theme by Anders Norén